Vepamusoro gumi Kambani Yemishonga muNyika 10

Yakapedzisira kugadziridzwa munaGunyana 7, 2022 na01:22 pm

Pano Unogona Kuona Rondedzero Yepamusoro gumi Pharmaceutical Kambani Munyika. The global musika wemishonga inotarisirwa kukura pamwero wepagore we3-6% mumakore anotevera, nehunyanzvi hwekutarisira mari inosvika makumi mashanu muzana ne50 mumisika mizhinji yakasimukira.

Heino rondedzero yePamusoro gumi Pharmaceutical Makambani Munyika.

Rondedzero yePamusoro gumi Pharmaceutical Kambani muNyika

saka heino runyorwa rwepamusoro gumi Pharmaceutical Kambani muNyika. Makambani emishonga anonyorwa nemugove wemusika wemishonga.

10. Sanofi

Sanofi ndiye mutungamiri wehutano hwehutano hwepasirese uye mumwe we makambani akanakisa emishonga. Iyo kambani Primary Care uye Specialty Care GBUs yaive yakatarisana chete pamisika yakakura. Chiratidzo chacho chiri pakati pemakambani epamusoro makumi maviri epasi rose emishonga.

Sanofi's Vaccines GBU ine hunyanzvi hwakasimba mufuruwenza, polio/pertussis/Hib, boosters uye meningitis. Pombi yayo inosanganisira mumiriri wejekiseni yekufema syncytial hutachiona hunogona kukonzera hutachiona hwemapapu muvana.

Turnover: $ 42 Bhiriyoni

The Consumer Healthcare GBU inopa kuzvitarisira mhinduro muzvikamu zvina zvikuru: allergy, kukosora uye kutonhora; kurwadziwa; utano hwekugaya; uye zvinovaka muviri. Iyo kambani iri pakati pemhando yepamusoro yepasi rose pharma brand.

9. GlaxoSmithKline plc

Iyo Kambani ine mabhizinesi matatu epasirese anoona, kuvandudza uye kugadzira mishonga yekuvandudza, majekiseni uye zvigadzirwa zvehutano zvevatengi. Zuva rega rega, mhando inobatsira kuvandudza hutano hwemamiriyoni evanhu pasi rose. Imwe yemakambani gumi epamusoro emishonga ekurapa oncology.

Turnover: $ 43 Bhiriyoni

Iyo kambani Pharmaceuticals bhizinesi ine yakafara portfolio yekuvandudza uye
yakagadzwa mishonga mukufema, HIV, immuno-inflammation uye oncology.
Iyo mhando iri kusimbisa R&D pombi kuburikidza nekutarisa kune immunology, yemunhu
genetics uye matekinoroji epamusoro kutibatsira kuona shanduko yemishonga mitsva yevarwere.

GSK ndiyo kambani hombe pasi rose yekudzivirira zvirwere nemari, kuendesa mishonga yekudzivirira
zvinodzivirira vanhu pamatanho ese ehupenyu. Iyo kambani R&D inotarisa mukusimudzira
majekiseni ekudzivirira zvirwere zvinotapukira anosanganisa kudiwa kwekurapa kwakanyanya uye kugona kwemusika kwakasimba.

8. Merck

Kwemakore zana nemakumi matatu, Merck (inozivikanwa seMSD kunze kweUS uye Kanadha) yanga ichigadzira hupenyu hwese, ichiunza mishonga nemishonga yekudzivirira zvirwere zvakawanda pasi rose mukutsvaga chinangwa chedu chekuponesa nekuvandudza hupenyu. Iyo kambani 8th yakakura pane rondedzero yePamusoro gumi Pharmaceutical Makambani.

Turnover: $ 47 Bhiriyoni

Iyo kambani inoshuvira kuve iyo yekutanga tsvakurudzo-yakanyanya biopharmaceutical kambani munyika uye makambani epamusoro emishonga. Mucherechedzo unoratidza kuzvipira kune varwere uye hutano hwevanhu nekuwedzera kuwanikwa kwehutano kuburikidza neanosvika kure marongero, zvirongwa uye kudyidzana.

Nhasi, mhando yacho inoramba iri pamberi pekutsvaga kudzivirira nekurapa zvirwere zvinotyisidzira vanhu nemhuka - kusanganisira kenza, zvirwere zvinotapukira, zvakadai seHIV neEbola, uye zvirwere zvemhuka zviri kubuda.

7.Novartis

Imwe yePamusoro 10 Pharmaceutical Companies Novartis Pharmaceuticals inounza mishonga yemhando yepamusoro kumusika kusimudzira hutano kuvarwere uye kupa mhinduro kune varapi vehutano vanovarapa. Novartis iri pamusoro pakati pezvinyorwa zvemakambani emishonga.

Turnover: $ 50 Bhiriyoni

AveXis ikozvino yave Novartis Gene Therapies. Novartis Gene Therapies yakatsaurirwa mukugadzira nekutengesa kurapa kwemajini kune varwere uye mhuri dzakaparadzwa nezvisingawanzo uye zvinotyisidzira hupenyu hweneurological genetic zvirwere. Novartis ndeyechinomwe murondedzero yemakambani makumi maviri epasi rose emishonga.

6. Pfizer

Kambani inoshandisa sainzi uye zviwanikwa zvepasirese kuunza marapirwo kuvanhu vanowedzera nekuvandudza hupenyu hwavo zvakanyanya kuburikidza nekuwanikwa, kusimudzira, kugadzira uye kugovera zvigadzirwa zvehutano, zvinosanganisira mishonga ine hunyanzvi uye majekiseni.

Turnover: $ 52 Bhiriyoni

Iyo kambani inoshanda pamisika yakasimukira uye ichiri kusimukira kusimudzira hutano, kudzivirira, marapirwo uye kurapwa zvinonetsa zvirwere zvinotyiwa zvakanyanya nenguva. Pfizer ndeye 6th mune rondedzero ye20 epamusoro makambani emishonga epasi rose.

Mucherechedzo uyu unoshanda nevarapi vehutano, hurumende uye nharaunda dzenharaunda kutsigira nekuwedzera kuwana kune yakavimbika, inokwanisika hutano hwehutano pasi rese. Iyo kambani iri pakati pePamusoro pasi rose pharma brand.

5. Bayer

Boka reBayer rinotungamirwa sekambani yesainzi yehupenyu ine zvikamu zvitatu - Pharmaceuticals, Consumer Health neCrop Science, izvo zviri kushumawo zvikamu. Iyo Inogonesa Mabasa inotsigira bhizinesi rinoshanda. Muna 2019, Bayer Boka raive nemakambani akabatanidzwa mazana matatu nemakumi mapfumbamwe nemaviri munyika makumi masere nenomwe.

Turnover: $ 52 Bhiriyoni

Bayer ikambani yeLife Science ine nhoroondo inopfuura 150-gore uye hunyanzvi hwakakosha munzvimbo dzehutano uye hutano. kurima. Nezvigadzirwa zvitsva, Chiratidzo chiri kubatsira mukutsvaga mhinduro kune mamwe matambudziko makuru enguva yedu.

Chikamu chePharmaceuticals chinotarisa pane zvigadzirwa zvemishonga, kunyanya zvemoyo uye hutano hwevakadzi, uye nehunyanzvi hwekurapa munzvimbo dzeoncology, hematology uye ophthalmology.

Chikamu ichi chinosanganisirawo bhizinesi reradiology, iro rinoshambadza diagnostic imaging michina pamwe chete neinodiwa inosiyanisa vamiririri. Bayer iri pakati pemakambani gumi epamusoro ezvemishonga emishonga.

4. Roche Boka

Roche yaive imwe yemakambani ekutanga kuunza marapirwo akananga kuvarwere nemakambani epamusoro emishonga. Iine simba rakasanganiswa mumishonga yemishonga uye diagnostics, kambani yakashongedzerwa zvirinani kupfuura chero imwe kambani kuenderera mberi nekutyaira yakasarudzika hutano hwehutano. 4th yakakura pane rondedzero yePamusoro gumi Pharmaceutical Makambani.

Turnover: $ 63 Bhiriyoni

Zvikamu zviviri muzvitatu zveKutsvagisa neKuvandudza mapurojekiti ari kuvandudzwa pamwe neanoongorora. Iyo kambani yanga iri pamberi pekutsvagisa cancer uye kurapwa kweanopfuura makore makumi mashanu, nemishonga yemazamu, ganda, colon, ovarian, mapapu uye akawanda mamwe makomarara. Iyo kambani iri pakati pePamusoro pasi rose pharma brand.

Chirwere ichi ndicho nhamba yepasi rose mubiotech ine 1 biopharmaceuticals pamusika. Inopfuura hafu yemakomponi mupombi yechigadzirwa ndeye biopharmaceuticals, inotigonesa kuendesa zvirinani-zvinonangwa marapirwo. Iyo kambani iri pakati pezvinyorwa zvePamusoro gumi Pharmaceutical Makambani.

3. Sinopharm

China National Pharmaceutical Group Co., Ltd. (Sinopharm) iboka guru rehutano hwehutano rakananga pasi peHurumende. midziyo Supervision and Administration Commission (SASAC) yeState Council, ine 128,000 vashandi uye cheni yakazara muindasitiri inofukidza R&D, kugadzira, zvinhu uye kugovera, chitoro cheni, hutano hwehutano, mabasa einjiniya, kuratidzwa uye makonferensi, bhizinesi repasi rese uye masevhisi emari.

Sinopharm ine makambani anopfuura chiuru nemazana uye makambani matanhatu akanyorwa. Sinopharm yakavaka nyika yese uye yekugovera network yezvinodhaka nemidziyo yekurapa nemidziyo, zvinosanganisira 1,100 logistic hubs, anopfuura makumi mana ematunhu-chikamu nzvimbo uye anopfuura mazana maviri nemakumi mana enzvimbo dzemadhorobha.

Turnover: $ 71 Bhiriyoni

Nekutanga iyo smart medical service system, Sinopharm inopa masevhisi emhando yepamusoro kune vanopfuura zviuru mazana maviri nemakumi matatu emakambani emakambani. Sinopharm ine yakashandiswa mishonga yekutsvagisa mishonga uye engineering dhizaini Institute, zvese zviri kutora chinzvimbo chinotungamira muChina.

MaAcademicians maviri eChinese Academy of Engineering, masangano gumi nerimwe enyika eR&D, nzvimbo makumi mana nemana dzematunhu ehunyanzvi hwekuita uye masayendisiti anopfuura zviuru zvishanu vakaita budiriro inoshamisa. Iyo kambani ndeimwe yeakanakisa makambani emishonga.

Sinopharm zvakare yakatungamira mukumisa nzira dzinopfuura mazana mashanu nemakumi matatu epasi rese tekinoroji, pakati peiyo EV530 yekudzivirira, chikamu chekutanga mushonga mutsva weChina neSinopharm vakabata yakakwana yakazvimirira yehungwaru kodzero, inoderedza kurwara kwechirwere chemaoko-tsoka-nemuromo pakati pevana veChinese. R&D nekuparurwa kwesIPV kunovimbisa kufambira mberi kwechirongwa chenyika chekudzivirira nhomba yeporiyo.

2. Johnson & Johnson

Johnson & Johnson nevatsigiri vayo (Kambani) vane vashandi vangangosvika 132,200 pasi rose vari kuita tsvagiridzo nekusimudzira, kugadzira uye kutengeswa kwezvakakura zvezvigadzirwa mumunda wehutano. 2nd mune rondedzero yePamusoro gumi Pharmaceutical Makambani

Turnover: $ 82 Bhiriyoni

Johnson & Johnson ikambani inobata, ine makambani anoshanda anoita bhizinesi munharaunda dzese dzepasi. Chinonyanya kutariswa neKambani zvigadzirwa zvine chekuita nehutano hwevanhu uye kugara zvakanaka. Johnson & Johnson akabatanidzwa muHurumende yeNew Jersey muna 1887.

Ndiyo imwe yemakambani gumi epamusoro emishonga yemishonga yeoncology. Iyo kambani inopa muzvikamu zvitatu zvebhizinesi: Consumer, Pharmaceutical uye Medical Devices. Iyo Pharmaceutical segment yakatarisana nenzvimbo nhanhatu dzekurapa:

Immunology (semuenzaniso, rheumatoid arthritis, kuzvimba bowel chirwere uye psoriasis),
Zvirwere zvinotapukira (semuenzaniso, HIV/AIDS),
Neuroscience (semuenzaniso, kusagadzikana kwepfungwa, neurodegenerative kusagadzikana uye schizophrenia),
Oncology (semuenzaniso, kenza yeprostate uye hematologic malignancies),
Mwoyo uye Metabolism (semuenzaniso, thrombosis uye chirwere cheshuga) uye
Pulmonary Hypertension (semuenzaniso, Pulmonary Arterial Hypertension).

Mishonga iri muchikamu ichi inogoverwa zvakananga kune vatengesi, vatengesi, zvipatara uye vashandi vehutano kuti vashandise mishonga. Kambani iyi ikambani yechipiri pakukura kwemishonga pasi rose.

1. China Zviwanikwa

China Resources (Holdings) Co., Ltd. ("CR" kana "China Resources Boka") ikambani inobata zvakasiyana-siyana yakanyoreswa kuHong Kong. CR yakatanga kugadzwa se "Liow & Co." muHong Kong muna 1938, uye yakazogadziridzwa zvakare ikatumidzwa zita rekuti China Resources Company muna 1948.

Muna 1952, panzvimbo yekuve yakabatana neHofisi Yese yeCPC Central Committee, yakauya pasi peCentral Trade Department (yava kunzi Ministry of Commerce). China Resources ndiyo makambani makuru emishonga pasi rose neRevenue.

Muna 1983, yakagadziridzwa zvakare kuve China Resources (Holdings) Co., Ltd. Muna Zvita 1999, CR yakanga isisabatike neBazi reKutengeserana Kwekunze neKudyidzana Kwehupfumi, uye yakava pasi pehutongi hwehurumende. Muna 2003, pasi pekutariswa kwakananga kweSASAC, yakave imwe yemabhizinesi akakosha ehurumende.

Turnover: $ 95 Bhiriyoni

Pasi peChina Resources Group pane nzvimbo shanu dzebhizinesi, dzinosanganisira zvigadzirwa zvevatengi, hutano, masevhisi emagetsi, kuvaka kwemadhorobha nekushanda, tekinoroji nemari, manomwe akakosha ebhizinesi mayuniti, 19 giredhi-1. batsiro nzvimbo, anenge 2,000 mabhizimisi masangano, uye vanopfuura 420,000 vashandi.

MuHong Kong, kune makambani manomwe akanyorwa pasi peCR, uye CR Land inzvimbo yeHSI. China zviwanikwa ndiyo yakakura Pharmaceutical kambani pasi rose nemugove wemusika.